ESTABLISHING THE CORRECT MANAGEMENT IN A PATIENT WITH MULTIPLE CRYPTOGENIC STROKES: ANTIPLATELET VS ANTICOAGULANT THERAPY

Ioan-Cristian Lupescu, Ioana Gabriela Lupescu, Adriana Octaviana Dulamea
2017 Romanian Journal of Neurology  
Cryptogenic strokes represent a category of ischemic strokes in which there is no well-defined cause identified. For that matter, choosing between antiplatelet and anticoagulant therapy can be challenging. We present the case of a 44 year old Caucasian male with a history of multiple ischemic strokes, with thrombophilia, but no atrial fibrillation or known cardio-embolic sources, who initially received anticoagulant treatment, which was switched in 2015 with Clopidogrel. Aspirin was added in
more » ... rin was added in 2017 after having a TIA in the left MCA territory. Despite dual antiplatelet therapy, the patient developed ischemic stroke in the left MCA territory, for which re-initiation of anticoagulant treatment was decided. Holter ECG, transthoracic and transesophageal echocardiography were performed, but failed to identify a cause.
doi:10.37897/RJN.2017.3.6 doaj:949d3285497445e89e63b775d7f1bb35 fatcat:byyit23e7bhdlhttclh2hvq6iq